Astera Labs, Inc. ALAB

NASDAQ Price as of Nov 17, 2026 · Fiscal year ended Dec 31, 2025 · Latest quarter Sep 30, 2026

$211.82
$97.89
$499.48
Market cap
$37.02B
P/E (GAAP, TTM)
84.39
P/E (operating)
213.48
Dividend yield
0.0%
Revenue growth YoY
153.7%
EPS growth YoY
98.0%
ROIC
14.5%
Piotroski F-score
6

Three ways to read the P/E

P/E (GAAP, TTM)
84.39

Net income of the last 4 quarters. Includes investment gains and one-time items.

P/E (GAAP, annual)
173.62

Net income of the latest fiscal year. Includes investment gains and one-time items.

P/E (operating)
213.48

After-tax operating income only: the core business.

P/E (excl. gains)
172.01

Net income after removing identified investment and asset-sale gains.

The operating P/E (213.48) is higher than the GAAP P/E (173.62), so net income is boosted by non-operating items such as interest, investment results or one-time items.

How it has changed

Values as they were known at each quarter-end. Green = moved in the better direction, red = worse.

Metric 2026Q3 2026Q2Change QoQ Year agoChange YoY
Revenue growth YoY (qtr) 104.5% 93.4%+11.1 pts ——
EPS growth YoY (qtr) 186.2% 144.4%+41.8 pts ——
Revenue growth (TTM) 98.5% 104.2%-5.7 pts ——
EPS growth (TTM) 22.4% 13.0%+9.4 pts ——
P/E (GAAP, TTM) 176.23 325.51-149.29 ——
P/E (operating) 368.56 498.78-130.22 ——
P/E (excl. gains) 296.96 401.89-104.93 ——
P/B 46.87 63.43-16.56 ——
ROIC 14.5% 14.5%0.0 pts ——
Net margin 25.7% 25.7%0.0 pts ——
Dividend yield 0.0% 0.0%0.0 pts ——
EPS (TTM) 2.02 1.48+36.5% ——
Price $355.98 $481.76-26.1% ——

History by quarter-end

Reported quarters

Quarter endedRevenueQoQYoY EPSQoQYoYNet margin
Sep 30, 2026 $584.90M 49.1% 153.7% 0.99 19.3% 98.0% 31.3%
Jun 30, 2026 $392.40M 27.3% 104.5% 0.83 88.6% 186.2% 39.0%
Mar 31, 2026 $308.36M 14.0% 93.4% 0.44 76.0% 144.4% 26.0%
Dec 31, 2025 * $270.58M 17.4% 91.8% 0.25 -50.0% -79.7% 16.6%
Sep 30, 2025 $230.58M 20.1% 103.9% 0.50 72.4% 1,100.0% 39.5%
Jun 30, 2025 $191.93M 20.4% 149.7% 0.29 61.1% 680.0% 26.7%
Mar 31, 2025 $159.44M 13.0% 144.3% 0.18 -85.4% 110.2% 20.0%
Dec 31, 2024 * $141.10M 24.8% 179.3% 1.23 2,560.0% 200.0% 17.5%
Sep 30, 2024 $113.09M 47.2% 206.2% -0.05 0.0% 37.5% -6.7%
Jun 30, 2024 $76.85M 17.8% 619.0% -0.05 97.2% 90.9% -9.8%
Mar 31, 2024 $65.26M 29.2% 269.4% -1.77 -531.7% -261.2% -142.5%
Dec 31, 2023 * $50.51M 36.8% — 0.41 612.5% — 28.4%

* Q4 is not filed separately. It is calculated as the fiscal year minus the first three quarters.

All figures

Price & size
Fiscal year end Dec 31, 2025 End date of the latest annual (10-K) report used.
Price date Nov 17, 2026 Date of the latest closing price used.
Price $211.82 Latest closing price.
Market cap $37.02B Price × shares outstanding.
Enterprise value $36.85B Market cap + debt − cash: the price of the whole business.
Shares 174.78M Shares outstanding used for market cap.
Valuation
P/E (GAAP, annual) 173.62 Price ÷ diluted earnings per share of the latest fiscal year. Uses NET income, so it includes investment gains and one-time items. Blank when earnings are negative.
P/E (GAAP, TTM) 84.39 Price ÷ the sum of the last four quarters of diluted EPS. Like P/E but more current. Includes investment gains and one-time items.
P/E (operating) 213.48 Market cap ÷ after-tax OPERATING income (latest fiscal year). Core business only: leaves out interest, investment gains and one-time items.
P/E (operating, TTM) 93.23 Market cap ÷ after-tax operating income of the last four quarters.
P/E (excl. gains) 172.01 Market cap ÷ net income after removing identified investment and asset-sale gains (after tax). Equals the GAAP P/E when no gains were identified.
PEG — P/E ÷ 3-year EPS growth rate (in %). Below 1 can mean growth is cheap.
PEG (TTM) 5.99 TTM P/E ÷ TTM EPS growth rate (in %).
Earnings yield 0.6% Net income ÷ market cap. The inverse of the P/E.
Earnings yield (TTM) 1.2% TTM EPS ÷ price.
P/B 27.15 Market cap ÷ shareholders' equity. Blank when equity is negative.
P/S 43.43 Market cap ÷ revenue of the latest fiscal year.
P/S (TTM) 23.79 Market cap ÷ revenue of the last four quarters.
P/FCF 131.40 Market cap ÷ free cash flow (operating cash flow − capital spending). Blank when FCF is negative.
EV/EBITDA 204.46 Enterprise value ÷ EBITDA. Useful for comparing companies with different debt levels.
EV/EBIT 212.51 Enterprise value ÷ operating income.
EV/Sales 43.23 Enterprise value ÷ revenue.
Book value / share 7.80 Shareholders' equity ÷ shares.
FCF yield 0.8% Free cash flow ÷ market cap.
Operating vs. one-time earnings
Operating EPS 0.99 After-tax operating income per share (latest fiscal year).
Investment gains $3.90M Gains (+) or losses (−) on investments inside net income, when the company reported them with the standard tags. Blank = none identified.
Asset-sale gains — One-time gains or losses from selling property, assets or businesses. Blank = none identified.
Non-operating income $44.73M Pre-tax income minus operating income: interest, investment results and one-time items combined.
Gains as % of net income 1.8% Identified investment and asset-sale gains (after tax) as a share of net income. A high value means reported earnings are flattered by non-core gains.
Latest quarter & trailing 12 months
Latest quarter Sep 30, 2026 End date of the most recent reported quarter.
Revenue (qtr) $584.90M Revenue of the latest reported quarter.
Net income (qtr) $182.94M Net income of the latest reported quarter.
EPS (qtr) 0.99 Diluted EPS of the latest reported quarter.
Revenue growth YoY (qtr) 153.7% Latest quarter revenue vs the same quarter a year earlier.
Revenue growth QoQ (qtr) 49.1% Latest quarter revenue vs the previous quarter.
EPS growth YoY (qtr) 98.0% Latest quarter EPS vs the same quarter a year earlier.
EPS growth QoQ (qtr) 19.3% Latest quarter EPS vs the previous quarter.
Net income growth YoY (qtr) 100.8% Latest quarter net income vs the same quarter a year earlier.
Net income growth QoQ (qtr) 19.5% Latest quarter net income vs the previous quarter.
Gross margin (qtr) 72.3% Gross profit ÷ revenue in the latest quarter.
Operating margin (qtr) 30.6% Operating income ÷ revenue in the latest quarter.
Net margin (qtr) 31.3% Net income ÷ revenue in the latest quarter.
Revenue (TTM) $1.56B Revenue of the last four quarters.
Net income (TTM) $461.32M Net income of the last four quarters.
EPS (TTM) 2.51 Sum of the last four quarters of diluted EPS.
Revenue growth (TTM) 115.2% Last four quarters of revenue vs the four quarters before.
EPS growth (TTM) 14.1% Last four quarters of EPS vs the four quarters before.
Net income growth (TTM) 132.0% Last four quarters of net income vs the four quarters before.
Dividends & shareholder returns
Dividend yield 0.0% Dividends paid per share over the last 12 months ÷ price.
Dividend / share (TTM) — Dividends per share paid over the last 12 months.
Payout ratio 0.0% Dividends per share ÷ EPS. Above 100% means the dividend exceeds earnings.
FCF payout ratio 0.0% Dividends ÷ free cash flow.
Dividend growth (1y) — Dividends per share vs the same 12-month window a year earlier.
Dividend CAGR (3y) — Annualised dividend growth over 3 years.
Dividend CAGR (5y) — Annualised dividend growth over 5 years.
Payments (12m) — Number of dividend payments in the last 12 months.
Last ex-dividend date — Most recent ex-dividend date.
Buyback yield 0.0% Share repurchases ÷ market cap.
Shareholder yield 0.0% Dividend yield + buyback yield.
Profitability
Gross margin 75.7% Gross profit ÷ revenue (latest fiscal year).
EBITDA margin 21.1% EBITDA ÷ revenue.
Operating margin 20.3% Operating income ÷ revenue.
Net margin 25.7% Net income ÷ revenue.
FCF margin 33.1% Free cash flow ÷ revenue.
ROE 16.1% Return on equity: net income ÷ shareholders' equity. Blank when equity is negative.
ROA 14.3% Return on assets: net income ÷ total assets.
ROIC 14.5% Return on invested capital: after-tax operating income ÷ (equity + debt − cash).
Growth (annual)
Revenue growth (annual) 115.1% Latest fiscal year revenue vs the year before.
Net income growth (annual) 362.7% Latest fiscal year net income vs the year before.
EPS growth (annual) 290.6% Latest fiscal year diluted EPS vs the year before.
Revenue CAGR (3y) 120.2% Annualised revenue growth over 3 fiscal years.
EPS CAGR (3y) — Annualised EPS growth over 3 fiscal years.
Financial health
Current ratio 10.24 Current assets ÷ current liabilities. Above 1 means short-term bills are covered.
Quick ratio 9.79 (Current assets − inventory) ÷ current liabilities.
Cash ratio 1.26 Cash ÷ current liabilities.
Debt / equity 0.00 Total debt ÷ shareholders' equity. Blank when equity is negative.
Debt / assets 0.00 Total debt ÷ total assets.
Debt / EBITDA 0.00 Total debt ÷ EBITDA: roughly how many years of earnings it takes to repay debt.
Net debt / EBITDA -0.93 (Debt − cash) ÷ EBITDA. Negative means more cash than debt.
Interest coverage — Operating income ÷ interest expense.
Earnings quality
FCF conversion 128.6% Free cash flow ÷ net income. Above 100% means profits turn into real cash.
Accruals ratio -6.5% (Net income − operating cash flow) ÷ assets. High values can signal low-quality earnings.
Stock comp % revenue 18.8% Share-based compensation ÷ revenue.
R&D % revenue 35.7% Research & development spending ÷ revenue.
SG&A % revenue — Selling, general & administrative expense ÷ revenue.
Tax rate used 0.0% Effective tax rate used for after-tax figures (capped 0–35%; 21% when unknown).
Efficiency
Asset turnover 0.56 Revenue ÷ total assets.
Days sales outstanding 36 Average days to collect payment from customers.
Days inventory 104 Average days inventory is held.
Days payables 75 Average days to pay suppliers.
Trading & momentum
52-week high $499.48 Highest price in the last 52 weeks.
52-week low $97.89 Lowest price in the last 52 weeks.
From 52-week high -57.6% How far below the 52-week high the price is (0% = at the high).
Above 52-week low 116.4% How far above the 52-week low the price is.
Avg volume (30d) 3.11M Average shares traded per day over the last 30 days.
Avg $ volume (30d) $704.95M Average dollars traded per day over the last 30 days: a liquidity measure.
Scores
Piotroski F-score 6 Nine yes/no tests of profitability, leverage and efficiency. 8–9 is strong, 0–2 is weak. Missing data counts as a fail.
Altman Z-score 133.98 Bankruptcy-risk score. Above 2.99 is safe, below 1.81 is distress. Not meaningful for banks and insurers.
Reported figures (latest fiscal year)
Revenue $852.53M Revenue of the latest fiscal year.
Net income $219.13M Net income of the latest fiscal year.
Diluted EPS 1.22 Diluted earnings per share of the latest fiscal year.
EBITDA $180.25M Operating income + depreciation & amortization.
Free cash flow $281.76M Operating cash flow − capital spending.
Total debt $0 Long-term plus current debt.
Cash $167.61M Cash and equivalents.
Equity $1.36B Shareholders' equity.
Total assets $1.53B Total assets.